In his final thoughts, Dr Gerds discusses emerging therapies for the treatment of PV.
Polycythemia Vera Guideline Updates 2023 | videos
Uncontrolled PV is highlighted by a key opinion leader.
Dr Gerds explores the pros and cons of the present treatment approach for PV.
Dr Gerds provides insight regarding the evaluation of dosing and effectiveness in PV treatment.
Dr Gerds navigates frontline treatments for patients diagnosed with PV.
Dr Gerds reviews the process for updating NCCN guidelines surrounding PV treatment.
Dr. Gerd examines the clinical choices involved in the management of PV, following the directives of NCCN guidelines.
Dr Gerds explores similarities and differences in symptomatic patients compared to asymptomatic patients with PV.
Risk factors for developing polycythemia vera (PV) are discussed by Aaron Gerds, MD, MS.
Advertisement
Advertisement
Trending on AJMC
1
Reduction in Food Allergies Found After Guideline-Directed Early Peanut Exposure
2
KEYNOTE-905 Paves the Way for Next Generation of MIBC Trials: Christof Vulsteke, MD, PhD
3
Adding Radioligand Therapy Pluvicto to SOC Cuts Risk of Prostate Cancer Progression or Death 28%, but How Many Doses?
4
FDA Expands Semaglutide Label to Reduce Cardiovascular Risk in Adults With Type 2 Diabetes
5
